Cannabidiol

Potential Contaminants in CBD and THC Oils

Cannabidiol (CBD) was initially discovered as a medication to treat Dravet syndrome, but is now used extensively to treat several medical and lifestyle disorders in addition to being used as recreational drug.

CBD Oil and Parkinson’s Disease

Can CBD Oil Be Used to Treat Epilepsy?

Does CBD Oil Work for Arthritis Pain?

Differences Between Cannabidiol (CBD) and Tetrahydrocannabinol (THC)

Can CBD be Used to Treat Drug Addiction?

Can CBD be Used to Prevent or Treat Psychosis?

Obesity Prevalence Among Cannabis Users

Does Diet Affect CBD Absorption?

Latest Cannabidiol News and Research

Handy homogeniser for cannabis sample preparation

The Chromatrap Spin Column Homogeniser from Porvair Sciences is gaining considerable interest from organizations preparing Cannabis samples for analysis of Tetrahydrocannabinol and Cannabidiol.

From Chromatrap® - Porvair Sciences Ltd 30 Mar 2020

Study shows legal marijuana products too strong for pain relief

Most legal marijuana products supplied to medical dispensaries are stronger than recommended for treatment of chronic pain.

26 Mar 2020

Accurate and informative labeling of CBD products is a critical public health issue

The need for accurate and informative labeling of hemp and hemp-derived cannabidiol (CBD) products is a critical public health issue.

25 Mar 2020

Vaporized cannabis increases drug-seeking behavior, study shows

Rats with regular access to cannabis seek more of the substance and tend to show increased drug-seeking behavior when cannabis is absent.

24 Mar 2020

Cannabidiol helps fight antibiotic-resistant bacteria

Since the discovery of penicillin in 1928 by Sir Alexander Fleming, antibiotics have saved millions of lives from fatal infections world-wide. However, with time bacteria have developed mechanisms to escape the effects of antibiotics - they have become resistant.

24 Mar 2020

Study looks at lung injury and vaping THC and vitamin E acetate

The US has witnessed a spate of patients presenting with acute lung injury associated with e-cigarettes or vaping product use. A new study published in the journal JAMA Internal Medicine shows the pattern of the outbreak in California where recreational cannabis use is legal and which has among the maximum cases of the strange illness.

8 Mar 2020

How cannabis interacts with medications

A new practice guideline published in the journal CMAJ in February 2020 describes five types of drug interactions possible with the use of cannabis. Cannabis is a plant-derived drug containing the psychoactive ingredient delta-9-tetrahydrocannabinol (THC) and non-psychoactive cannabidiol (CBD). These cannabinoids are broken down by the liver enzymes cytochrome P450 C(YP)34A, and CYP2CC9.

2 Mar 2020

Cases of poisoning attributed to manipulated cannabidiol liquids in e-cigarettes

The health risks of e-cigarettes have come into focus after the deaths of several “vapers” due to lung injury in the USA recently.

27 Feb 2020

Researchers uncover hidden antibiotic potential of cannabis compound

Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity's most critical challenges. However, scientists haven't discovered a new class of antibiotics in more than 30 years.

26 Feb 2020

Study provides insight into how CBD influences the brains of people with psychosis

Published in Psychological Medicine, the research used fMRI scans to examine the brain activity of 13 people with a diagnosis of psychosis under the influence of a single dose of CBD or placebo and 16 controls whilst they were undertaking a memory task.

29 Jan 2020

Pulmonary imaging key to diagnosing vaping-related lung damage

In 2019, the emergence of mysterious lung disease in the United States has sparked global health attention. Now named as the e-cigarette, or vaping, product use–associated lung injury (EVALI), the disease causes lung damage, which is a serious and sometimes fatal complication of vaping.

28 Jan 2020

Researchers identify how marijuana accelerates growth of HPV-related head and neck cancer

University of California San Diego School of Medicine researchers have identified the molecular mechanism activated by the presence of tetrahydrocannabinol (THC) - the ingredient that causes people to feel the euphoria or "high" associated with cannabis - in the bloodstream that accelerates cancer growth in patients with human papillomavirus (HPV)-positive head and neck squamous cell carcinoma.

13 Jan 2020

Inhaled cannabis cuts headache and migraine severity by nearly half

Inhaled cannabis reduces self-reported headache severity by 47.3% and migraine severity by 49.6%, according to a recent study led by Carrie Cuttler, a Washington State University assistant professor of psychology.

25 Nov 2019

Study may help explain effects of cannabidiol on seizure frequency in Lennox-Gastaut patients

Results from a study published in the British Journal of Clinical Pharmacology may help explain why cannabidiol--a chemical component of marijuana with no psychoactive properties--reduces the frequency of seizures in patients with a severe form of epilepsy.

7 Nov 2019

Single vaping episode of cannabis could yield positive results in urine drug tests

In a study of six adults, Johns Hopkins Medicine researchers report evidence that a single vaping episode of cannabis that is similar in chemical composition to that found in legal hemp products could possibly result in positive results on urine drug screening tests commonly used by many employers and criminal justice or school systems.

From Johns Hopkins Medicine 4 Nov 2019

Cannabis is not an effective treatment for mental health conditions, conclude experts

A team in Australia has reviewed scientific evidence from the past 30 years to investigate the therapeutic effects of medicinal cannabinoids on mental health.

30 Oct 2019

Most women of childbearing age may be less skeptical about the safety of CBD

While most women of childbearing age understand drinking alcohol while pregnant is harmful, they may be less skeptical about the safety of cannabidiol, even though there is no evidence to support that belief, suggests a study being presented at the ANESTHESIOLOGY 2019 annual meeting.

20 Oct 2019